natgillin/translations-raw huggingface dataset:
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Nobilis OR Inac exceed the risks for passive immunistaion of broilers induced by active immunisation of female broiler breeders to reduce infection with O. rhinotracheale serotype A when this agent is involved, and recommended that Nobilis OR Inac be given a marketing authorisation. 
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je odločil, da so koristi zdravila Nobilis OR Inac za pasivno imunizacijo brojlerjev z aktivno imunizacijo kokoši brojlerskih matičnih jat z namenom zmanjšanja okužbe z O. rhinotracheale serotipa A, kadar je ta bakterija prisotna, večje od z njim povezanih tveganj.
What benefit has Nobilis OR Inac shown during the studies? 
Kakšne koristi je zdravilo Nobilis OR Inac izkazalo med raziskavami?
Why has Nobilis OR Inac been approved? 
Zakaj je bilo zdravilo Nobilis OR Inac odobreno?
The withdrawal period is zero days. 
Karenca je nič dni.
How has Nobilis OR Inac been studied? 
Kako je bilo zdravilo Nobilis OR Inac raziskano?
What is Nobilis OR Inac used for? 
Za kaj se zdravilo Nobilis OR Inac uporablja?
What is Nobilis OR Inac? 
Kaj je zdravilo Nobilis OR Inac?
How does Nobilis OR Inac work? 
Kako zdravilo Nobilis OR Inac deluje?
1 cartridge + 1 pack with 3 pen needles 
1 pakiranje s 3 iglami za peresnik
This overview was last updated in October 2019. 
Povzetek je bil nazadnje posodobljen oktobra 2019.
Local reactions resolve without treatment. 
Lokalne reakcije izzvenijo brez zdravljenja.
Direct contact with the medicine should be avoided. 
Izogibati se je treba neposrednemu stiku z zdravilom.
Therefore it is recommended to treat the cat in the evening. 
Zato se priporoča, da se zdravilo mački nanese zvečer.
Further information on Mirataz can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/mirataz. 
Nadaljnje informacije o zdravilu Mirataz so na voljo na spletni strani agencije: ema.europa.eu/medicines/veterinary/EPAR/mirataz.
The average weight gain after 14 days was approximately 130 g per cat and significantly higher than the average 10 g in the group receiving placebo (dummy treatment). 
Povprečen prirast telesne mase po 14 dneh je znašal približno 130 g na mačko in je bil znatno višji od povprečnega prirasta v višini 10 g v skupini, ki je prejemala placebo (zdravilo brez učinkovine).
Serotonin syndrome is a potentially serious condition that may occur with medicines that raise serotonin levels in the body. 
Serotoninski sindrom je potencialno resno stanje, ki se lahko pojavi pri uporabi zdravil, ki povečujejo raven serotonina v telesu.
The European Medicines Agency decided that Mirataz's benefits are greater than its risks and it can be authorised for use in the EU. 
Evropska agencija za zdravila je odločila, da so koristi zdravila Mirataz večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
Mirataz received a marketing authorisation valid throughout the EU on 10 December 2019. 
Zdravilo Mirataz je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 10/12/2019.
In the case of contact with eyes, rinse the eyes thoroughly with clean water. 
V primeru stika z očmi si je treba temeljito sprati oči s čisto vodo.
It is recommended that pregnant women or women trying to conceive avoid handling the medicine and contact with treated animals throughout the treatment period. 
Priporoča se, da se nosečnice ali ženske, ki skušajo zanositi, izogibajo ravnanju z zdravilom in stiku z zdravljenimi živalmi v celotnem obdobju zdravljenja.
The medicine is applied topically to the inner pinna (inner surface of the ear) once daily for 14 days. 
Zdravilo se nanese lokalno na notranji del uhlja (notranjo površino uhlja) enkrat na dan 14 dni zapored.
It contains the active substance mirtazapine. 
Vsebuje učinkovino mirtazapin.
Mirtazapine is absorbed through the skin of the ear into the bloodstream. 
Mirtazapin se absorbira skozi kožo uhlja v krvni obtok.
Only one ear is treated each day, so the left ear one day and the right ear the following day. 
Mazilo se vsak dan nanese samo na en uhelj, na primer na levi uhelj prvi dan in desni uhelj naslednji dan.
People must not eat, drink or smoke while handling the medicine. 
Uporabniki med rokovanjem z zdravilom ne smejo jesti, piti ali kaditi.
A clinical field trial performed in the US in cats who had at least 5% weight loss due to an underlying medical condition, showed that 14 days' treatment with Mirataz increased their bodyweight. 
Klinično terensko preskušanje, opravljeno v ZDA pri mačkah, ki so utrpele vsaj 5-odstotno izgubo telesne mase zaradi bolezni, je pokazalo, da se je po 14 dneh zdravljenja z zdravilom Mirataz njihova telesna masa povečala.
They include blocking some of the actions of serotonin and histamine, substances involved in the regulation of appetite, and an effect on levels of leptin, a hormone that controls hunger. 
Vključujejo zaviranje nekaterih funkcij serotonina in histamina, tj. snovi, ki sodelujejo pri uravnavanju apetita, in učinkovanje na ravni leptina, tj. hormona, ki nadzoruje lakoto.
People who are hypersensitive (allergic) to mirtazapine should avoid contact with Mirataz. 
Ljudje, ki so preobčutljivi za (alergični na) mirtazapin, se morajo izogibati stiku z zdravilom Mirataz.
The most common side effects with Mirataz (which may affect more than 1 in 10 cats) are signs of local irritation or inflammation at the site where the ointment is applied and behavioural changes (increased meowing, hyperactivity, disoriented state or inability to co-ordinate muscle movements, lack of energy/weakness, attention seeking and aggression). 
Najpogostejši neželeni učinki zdravila Mirataz (ki se lahko pojavijo pri več kot 1 od 10 mačk) so znaki lokalnega draženja ali vnetja na mestu nanosa mazila in vedenjske spremembe (pogostejše mijavkanje, hiperaktivnost, dezorientiranost ali nezmožnost usklajevanja mišičnih gibov, pomanjkanje energije/oslabelost, iskanje pozornosti in agresivnost).
The medicine can be absorbed via the skin or mouth and can cause drowsiness or sedation. 
Zdravilo se lahko absorbira prek kože ali peroralno in lahko povzroči zaspanost ali sedacijo.
Treated cats should not be allowed to sleep with owners, especially children and pregnant women, during the entire treatment period. 
V celotnem obdobju zdravljenja zdravljene mačke ne smejo spati z lastniki, zlasti ne z otroki in nosečnicami.
If a dose is missed, the medicine can be applied the following day and daily dosing resumed. 
V primeru izpustitve odmerka se zdravilo nanese naslednji dan, zatem pa se nadaljuje dnevno odmerjanje.
Mirataz must not be used in cats treated with the medicines cyproheptadine, tramadol or monoamine oxidase inhibitors (MAOIs) or treated with an MAOI in the 14 days before treatment with Mirataz, as there may be an increased risk of serotonin syndrome. 
Ne sme se uporabljati pri mačkah, zdravljenih s ciproheptadinom, tramadolom ali zaviralci monoaminooksidaze (MAOI) ali zdravljenih z zaviralci monoaminooksidaze zadnjih 14 dni pred pričetkom zdravljenja z zdravilom Mirataz, ker lahko pride do povečanega tveganja za serotoninski sindrom.
What is Mirataz and what is it used for? 
Kaj je zdravilo Mirataz in za kaj se uporablja?
An overview of Mirataz and why it is authorised in the EU 
Pregled zdravila Mirataz in zakaj je odobreno v EU
What benefits of Mirataz have been shown in studies? 
Kakšne koristi je zdravilo Mirataz pokazalo v študijah?
Why is Mirataz authorised in the EU? 
Zakaj je bilo zdravilo Mirataz odobreno v EU?
The signs can range from mild to severe and include fever, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea, convulsions and seizures. 
Bolezenski znaki so lahko blagi do resni in vključujejo povišano telesno temperaturo, nemir, povečane reflekse, tresenje, potenje, razširjene zenice, drisko, konvulzije in epileptične napade.
The medicine is available as an ointment to be applied on the skin. 
Zdravilo je na voljo v obliki mazila, ki se nanese na kožo.
Other information about Mirataz 
Druge informacije o zdravilu Mirataz
The effects of mirtazapine on weight gain are complex and not fully understood. 
Učinki mirtazapina na povečanje telesne mase so večplastni in niso še povsem pojasnjeni.
Mirataz must not be used in breeding, pregnant or lactating cats, in cats less than 7.5 months of age or less than 2 kg bodyweight. 
Zdravilo Mirataz se ne sme uporabljati pri vzrejnih živalih, brejih mačkah ali mačkah v laktaciji, mačkah, starih manj kot sedem mesecev in pol ali tistih, ki tehtajo manj kot 2 kg.
What are the risks associated with Mirataz? 
Kakšna tveganja so povezana z zdravilom Mirataz?
Hand to mouth and hand to eye contact should be avoided until hands have been thoroughly washed. 
Preprečiti je treba prenos zdravila z rokami v usta in z rokami v oči, dokler si temeljito ne umijete rok.
For more information about using Mirataz, see the package leaflet or contact your veterinarian or pharmacist. 
Za več informacij glede uporabe zdravila Mirataz glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
Impermeable disposable protective gloves should be provided when the medicine is purchased and these must be worn when handling and applying the medicine. 
Ob nakupu zdravila je treba zagotoviti neprepustne zaščitne rokavice za enkratno uporabo, ki jih je treba nositi med uporabo in nanašanjem zdravila.
If skin or eye irritation occurs, or in case of accidental ingestion, medical advice should be sought immediately and the label shown to the doctor. 
Če pride do draženja kože ali oči ali v primeru nenamernega zaužitja, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
Mirataz is a skin sensitiser and may cause eye and skin irritation. 
Zdravilo Mirataz je povzročitelj preobčutljivosti kože ter lahko povzroči draženje oči in kože.
Contact should be avoided with the treated cat for the first 12 hours after each daily application. 
V prvih 12 urah po vsaki uporabi se je treba izogibati stiku z zdravljeno mačko.
The tube must be placed in the child-proof container after application, which must be closed immediately. 
Tubo je treba po nanosu zdravila vstaviti nazaj v vsebnik, varen za otroke, in ga takoj zapreti.
The tube must not be left out of its child-proof container except while applying the medicine. 
Tuba mora vedno biti v vsebniku, varnim za otroke, razen med nanašanjem zdravila.
For the full list of side effects and restrictions of Mirataz, see the package leaflet. 
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Mirataz glejte navodilo za uporabo.
How does Mirataz work? 
Kako zdravilo Mirataz deluje?
Thoroughly wash hands immediately after application of the medicine or in case of skin contact with the medicine or the treated cat before the application site is dry. 
Takoj po uporabi zdravila ali v primeru kožnega stika z zdravilom ali zdravljeno mačko, preden je mesto nanosa suho, je treba takoj temeljito oprati roke.
Mirataz is a medicine used to produce an increase in bodyweight in cats with long-term conditions known to cause poor appetite and weight loss. 
Mirataz je zdravilo, ki se uporablja za povečanje telesne mase pri mačkah, ki imajo slab apetit in hujšajo zaradi kroničnih bolezenskih stanj.
It can only be obtained with a prescription. 
Predpisovanje in izdaja zdravila je le na recept.
How is Mirataz used? 
Kako se zdravilo Mirataz uporablja?
The medicine may be harmful after ingestion and should be kept away from children, who should not be present when the cat is treated. 
Zdravilo ima lahko škodljive učinke pri zaužitju, zato ga je treba hraniti tako, da je nedosegljivo otrokom.
INSTRUCTIONS ON USE 16. 
NAVODILA ZA UPORABO 16.
General information about taking this medicine: 
Splošne informacije o jemanju tega zdravila:
This medicine can be very damaging to your unborn baby (embryo). 
To zdravilo je lahko zelo škodljivo za nerojenega otroka (embrio).
This should be discussed with your doctor. 
O tem se pogovorite s svojim zdravnikom.
For additional details see section 4.5. 
Za dodatne podrobnosti glejte poglavje 4.5.
For laboratory monitoring of pregnancy, please refer to Laboratory tests. 
Za laboratorijske kontrole nosečnosti, prosimo, glejte Laboratorijske preiskave.
No data are available in children below 3 years of age. 
Podatkov pri otrocih, mlajših od 3 let, ni na voljo.
If you have this reaction, be sure to rinse your mouth thoroughly afterwards 
Če pride do te reakcije, si morate potem temeljito sprati usta.
Suicide* 
samomor*
Long-term efficacy data - Adults 
Dolgoročni podatki o učinkovitosti - odrasli
Date of first authorisation : 01 July 2009 Date of latest renewal : 16 January 2014 
Datum pridobitve dovoljenja za promet: 01. julij 2009 Datum podaljšanja dovoljenja za promet: 16.januar 2014
Not known side effects (frequency cannot be estimated from the available data): 
Neznani neželeni učinki (pogostnosti ni mogoče oceniti iz razpoložljivih podatkov):
However, a return to higher doses is not recommended. 
Vendar pa vrnitev na večje odmerke ni priporočljiva.
For males, clearance was approximately 20 % higher than for females. 
Pri moških je bil očistek približno 20 % večji kot pri ženskah.
This interaction is not considered to be clinically relevant. 
Ta interakcija ni klinično pomembna.
You should brush your teeth thoroughly twice daily and have regular dental examinations. 
Temeljito si morate očistiti zobe dvakrat na dan in redno hoditi na preglede k zobozdravniku.
The study results are summarized in Table 9. 
Povzetek izsledkov študije je podan v preglednici 9.
Survival of foetuses and offspring was reduced. 
Preživetje plodov in potomcev je bilo zmanjšano.
• have HIV (human immunodeficiency virus) or have ever had any other problems with your immune system. 
• imate virus humane imunske pomanjkljivosti (HIV) oziroma imate ali ste kdaj imeli kakšne druge težave z imunskim sistemom.
Therefore, your blood will be checked regularly to be sure that the HIV infection is not getting worse. 
Zato boste redno opravljali krvne preiskave, da se prepričamo, da se okužba z virusom HIV ne slabša.
Less than 30 mL/min 
Manj kot 30 ml/min
This was true for all HCV genotypes. 
To je veljalo za vse HCV genotipe.
• Girl or woman of childbearing age: 
• Dekle ali ženska v rodni dobi:
In terms of activity, about one-third of sustained responders showed improvement and none showed worsening. 
Kar zadeva aktivnost bolezni, se je pri približno eni tretjini bolnikov s trajnim odzivom pokazalo izboljšanje, pri nobenem od bolnikov pa ni prišlo do poslabšanja.
Volume of distribution is approximately 5,000 l. Ribavirin does not bind to plasma proteins. 
Volumen porazdelitve je približno 5.000 l. Ribavirin se ne veže na plazemske beljakovine.
Study 22 
Študija 22
In addition some patients may experience vomiting. 
Poleg tega lahko nekateri bolniki tudi bruhajo.
• Inability to achieve full adult height may occur in some children and adolescents 
• Nezmožnost doseganja popolne odrasle višine pri nekaterih otrocih in mladostnikih.
Tell your doctor or pharmacist as soon as possible. 
Čimprej obvestite svoje zdravnika ali farmacevta.
Your physician will prescribe the pack size which is best for you. 
Zdravnik vam bo predpisal velikost pakiranja, ki je za vas najbolj primerna.
Male patients and their female partners 
Bolniki in njihove partnerke
Talk to your doctor if you or your child you are caring for: 
Zdravniku povejte, če ste vi ali otrok za katerega skrbite:
If you are pregnant you must not take this medicine. 
Če ste noseči ne smete jemati tega zdravila.
Be sure to seek emergency care if you notice that you are becoming depressed or have suicidal thoughts or change in your behaviour. 
Poiščite nujno zdravniško pomoč, če opazite, da postajate depresivni ali imate samomorilne misli oziroma se vaše obnašanje spremeni.
If the child/adolescent weighs 
Če otrok/mladostnik tehta
7 months after stopping treatment. 
in še sedem mesecev po koncu zdravljenja.
Elderly ( 65 years of age) 
Starejši (stari  65 let)
Overall Responsea (n=118) Genotype 1 (n=92) Genotype 2/3/4 (n=26) 
Skupni odziva (n=118) Genotip 1 (n=92) Genotip 2/3/4 (n=26)
- Depending upon the results of these tests, your doctor may change/adjust the number of tablets you or the child you are caring for take, prescribe a different pack size of this medicine, and/or change the length of time to take this treatment. 
- Glede na izvide teh preiskav bo zdravnik lahko spremenil/prilagodil število tablet, ki jih vi ali otrok, za katerega skrbite, jemljete, in vam predpisal drugo velikost pakiranja tega zdravila in/ali spremenil dolžino zdravljenja.
Hepatotoxicity (including fatalities)* 
hepatotoksičnost (vključno s smrtnimi primeri)*
Although not all of these unwanted effects may occur, they may need medical attention if they do occur. 
Čeprav ni nujno, da se bodo pri vas pojavili vsi ti neželeni učinki, če pa se, boste morda potrebovali zdravniško pomoč.
Upon discontinuation of dosing the half-life was approximately 298 hours, which probably reflects slow elimination from non-plasma compartments. 
Po prekinitvi odmerjanja je bila razpolovna doba približno 298 ur, kar je verjetno odraz počasnega izločanja zdravila iz neplazemskih prostorov.
The clinical relevance of results from this single dose study is unknown. 
Klinični pomen izsledkov te študije z enkratnim odmerkom ni znan.
Ribavirin accumulates intracellularly and is cleared from the body very slowly. 
Ribavirin se namreč kopiči intracelularno in se iz telesa izloča zelo počasi.
Take/administer the missed dose as soon as possible during the same day. 
Vzemite/dajte pozabljeni odmerek čim prej še v istem dnevu.
The incidence and severity of teratogenic effects increased with escalation of the dose. 
Pojavnost in jakost teratogenih učinkov sta se povečevali z večanjem odmerka.
You may want to consider asking a family member or close friend to help you stay alert to signs of depression or changes in your behaviour 
Po potrebi prosite družinskega člana ali bližnjega prijatelja, naj vam pomaga biti pozoren na znake depresije ali spremembe vedenja.
Caution should be exercised when both medicines are co-administered. 
Med uporabo obeh zdravil je potrebna previdnost.
Study 11 
Študija 11
• have problems with your kidneys. 
• imate težave z ledvicami,
Do not use this medicine if you notice any change in the appearance of the tablets. 
Ne uporabljajte tega zdravila če opazite, da je izgled tablet spremenjen.
Clearance increased as a function of body weight and was reduced at ages greater than 40 years. 
Očistek se je povečeval kot funkcija telesne mase in je upadal po 40. letu.
This type of transporter is present on virtually all cell types and may account for the high volume of distribution of ribavirin. 
Ta vrsta prenašalca je prisotna na skoraj vseh vrstah celic in je morda odgovorna za velik porazdelitveni volumen ribavirina.
• had a previous heart condition or have heart disease. 
• imeli težave s srcem v preteklosti ali imate bolezen srca,
In all cases the treatment was for one year with a follow-up of six months. 
V vseh primerih je zdravljenje trajalo eno leto z nadaljnjim šestmesečnim spremljanjem bolnikov.
Do not drive or use any tools or machines if you feel tired or sleepy, or are confused. 
Ne vozite avtomobila in ne upravljajte z orodji ali stroji, če občutite utrujenost, zaspanost ali zmedenost.
 2 g/dL decrease in haemoglobin during any 4 week period during treatment (permanent dose reduction) 
 2 g/dl znižanje hemoglobina v katerem koli 4-tedenskem obdobju med zdravljenjem (stalno zmanjšanje odmerka)
< 12 g/dL despite 4 weeks at reduced dose 
< 12 g/dl kljub 4-tedenski uporabi manjšega odmerka
- Blood tests will be done regularly to help your doctor to know if this treatment is working. 
- Redno boste opravljali krvne preiskave, da bo zdravnik ugotovil, ali zdravljenje pri vas deluje.
Do not have sex with a pregnant woman unless you use a condom. 
Ne smete imeti spolnih odnosov z nosečo žensko brez uporabe kondoma.
Both female and male patients must take special precautions in their sexual activity if there is any possibility for pregnancy to occur: 
Tako bolnice kot bolniki morajo biti posebno previdni pri spolnih odnosih, če obstaja kakršnakoli možnost za zanositev:
Anorexia, increased appetite, decreased appetite 
anoreksija, povečan apetit, zmanjšan apetit
The patient was observed for two days in the emergency room, during which time no adverse reaction from the overdose was noted. 
Bolnika so opazovali dva dni na urgentnem oddelku in v tem času niso ugotovili nobene neželene reakcije zaradi prevelikega odmerka.
Reduce ribavirin dose* if: 
Odmerek ribavirina zmanjšajte*, če:
Suicide attempts, panic attack, hallucination 
poskus samomora, napad panike, halucinacije
No histopathological effects on bone were observed. 
Pri tem niso opažali nikakršnih histopatoloških učinkov na kosti.
Use of nucleoside analogs, alone or in combination with other nucleosides, has resulted in lactic acidosis. 
Uporaba nukleozidnih analogov, samih ali v kombinaciji z drugimi nukleozidi, je povzročila laktacidozo.
Dose modifications were required in 30 % of patients, most commonly for anaemia and neutropenia. 
Prilagoditev odmerka je bila potrebna pri 30 % bolnikov, najpogosteje zaradi anemije in nevtropenije.
• have another liver problem in addition to hepatitis C infection. 
• imate poleg okužbe s hepatitisom C še kakšno drugo težavo z jetri,
Haemodialysis (ESRD) 
Hemodializa (ESRD)
Furthermore, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4 % vs 1 %) during treatment and during the 6 month follow-up after treatment. 
Poleg tega so pri pediatričnih bolnikih pogosteje poročali o samomorilnih mislih ali poskusih samomora kot pri odraslih bolnikih (2,4 % v primerjavi z 1 %) med zdravljenjem in v 6-mesečnem obdobju spremljanja bolnikov po zdravljenju.
This will lessen the possibility for ribavirin to be left in the woman's body. 
Tako boste zmanjšali možnost za prehajanje ribavirina v telo ženske.
Like all medicines, this medicine used in combination with other medicines can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi to zdravilo v kombinaciji z drugimi zdravili neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
At the end of the recovery period, tibial and femoral changes were minimal although generally statistically significant compared to controls in males at all dose levels and in females dosed with the two highest doses compared to controls. 
Ob koncu obdobja okrevanja so bile spremembe na tibialni in femoralni kosti minimalne, čeprav so bile na splošno statistično pomembne v primerjavi s kontrolno skupino samcev pri vseh velikostih odmerka ter pri samicah, ki so prejemale dva največja odmerka v primerjavi s kontrolno skupino.
Please refer to the Package Leaflet of (peg)interferon alfa for more detailed information on these safety issues. 
Glejte navodilo za uporabo (peg)interferona alfa za podrobnejše informacije o teh varnostnih vprašanjih.
Paediatric patients (children 3 years of age and older and adolescents) 
Pediatrični bolniki (otroci, stari 3 leta ali več, in mladostniki)
These include: 
Med njimi so:
Anaemia occurs shortly after initiation of dosing, but is rapidly reversible upon cessation of treatment. 
Anemija se pojavi kmalu po začetku prejemanja zdravila, vendar je hitro reverzibilna po koncu zdravljenja.
Liver biopsies were obtained before and after treatment in Study 1 and were available for 210 of the 412 subjects (51 %). 
V študiji 1 so biopsijo jeter opravili pred in po zdravljenju - na voljo so podatki za 210 od 412 preiskovancev (51 %).
The majority of adverse reactions reported in the study were mild or moderate in severity. 
Neželeni učinki, o katerih so poročali v tej študiji, so bili po jakosti večinoma blagi ali zmerni.
Population pharmacokinetic analysis was performed using sparsely sampled serum concentration values from four controlled clinical trials. 
Populacijska farmakokinetična analiza je bila opravljena z uporabo redko vzorčenih serumskih koncentracij iz štirih kontroliranih kliničnih preskušanj.
Potential to exacerbate immunosuppression 
Možnost za poslabšanje imunosupresije